64764-944 : Edarbyclor 40/12.5 (Azilsartan Medoxomil (Azilsartan Kamedoxomil 42.68 mg) / Chlorthalidone) Oral Tablet


NDC64764-944
Labeler: Takeda Pharmaceuticals America, Inc.
Product Type: Human Prescription Drug
Drug Name:  Edarbyclor
Dosage Form: Oral Tablet
Application #: NDA202331
Rev. Date: 


Appearance:


Markings: AC;40;12;5
Shapes:  Round
Colors:  Red
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

AC 40 12 5: (64764-944) Edarbyclor 40/12.5 (Azilsartan Medoxomil (Azilsartan Kamedoxomil 42.68 mg) / Chlorthalidone) Oral Tablet by Takeda Pharmaceuticals America, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 64764-944-07: 5 CARTON IN 1 TRAY (64764‑944‑07) > 1 BLISTER PACK IN 1 CARTON > 7 TABLET IN 1 BLISTER PACK
  • 64764-944-30: 30 TABLET IN 1 BOTTLE (64764‑944‑30)
  • 64764-944-90: 90 TABLET IN 1 BOTTLE (64764‑944‑90)

Active Ingredients:

  • Azilsartan Kamedoxomil
  • Chlorthalidone

Dosage Strength:

  • 40 mg
  • 12.5 mg

Inactive Ingredients:

  • Mannitol
  • Cellulose, Microcrystalline
  • Talc
  • Titanium Dioxide
  • Ferric Oxide Red
  • Polyethylene Glycol 8000
  • Butyl Alcohol
  • Crospovidone
  • Water
  • Fumaric Acid
  • Sodium Hydroxide
  • Hydroxypropyl Cellulose
  • Magnesium Stearate
  • Hypromelloses
  • Shellac
  • Ferrosoferric Oxide
  • Alcohol

Pharmaceutical Classes:

  • Angiotensin 2 Type 1 Receptor Antagonists [MoA]
  • Angiotensin 2 Receptor Blocker [EPC]
  • Decreased Blood Pressure [PE]
  • Increased Diuresis [PE]
  • Thiazide-like Diuretic [EPC]

Related Products:

Based on records with the same trade name.
  • 64764-994 Edarbyclor 40/25 Oral Tablet by Takeda Pharmaceuticals America, Inc.
  • 60631-412 Edarbyclor Oral Tablet by Arbor Pharmaceuticals Ireland Limited
  • 60631-425 Edarbyclor Oral Tablet by Arbor Pharmaceuticals Ireland Limited
  • 75929-230 Edarbyclor Oral Tablet by Pharma Packaging Solutions, LLC Dba Tjoapack LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 64764-944 QR Code

< Prev: 64764-918Next: 64764-994 >

Related Discussions:

Chlorthalidone issues
I was put on 25 mg. of chlortalidone several months ago. I lost a lot of weight and felt terrible. I contacted my dr. an... 7 replies
Chlorthalidone Use
In my research on Chlorthalidone, I have come upon information that may have a drastic impact on the use of this type of... 4 replies
chlorthalidone and increased risk of diabetes
This drug has been linked to diabetes in quite a few people, which is the reason why i've decided to no longer take ... 3 replies
Chlorthalidone and coughing side effect
After two weeks of taking Chlorthalidone I have a maddening cough, yet my lungs are clear. Anyone else experience this? ... 2 replies
Chlorthalidone made me ill
I started on this bp med 25mg. for the first time and on the 3rd day started to feel a little ill. Called doc, said what... 2 replies
Chlorthalidone Reviews
Has anyone experienced side effects from taking Chlorthalidone? ## Can Chlorthalidone 25 mg and Lotensin 20mg combined c... 2 replies
Chlorthalidone 25mg and bruising
I have been taking Chlorthalidone 25mg since June 2012. Prior to starting this medicine I noticed that I bruise very eas... 2 replies
Chlorthalidone side effects
Sir I take amlodac ch and some time I drop my doctor started ctd.6.25 and tellzy rs but some side effect shown just like... 1 reply
Chlorthalidone horrible side effects
I started taking this drug 2 days ago as the beta blocker I was on was making me feel terrible but I am having the same ... 1 reply
Chlorthalidone and Parkinsons
I have essential tremor and I have recently been prescribed chlorthalid. I would like to know if there is newer informat... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.